N-[1(S)-(Hydroxymethyl)-2-[(RS)-[[(RS)-methylsulfinyl]methyl]sulfinyl]ethyl]-3-(6-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-2(E)-propenamide (174390-02-4)

Identification
Name:	N-[1(S)-(Hydroxymethyl)-2-[(RS)-[[(RS)-methylsulfinyl]methyl]sulfinyl]ethyl]-3-(6-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-2(E)-propenamide
Synonyms:	Sparoxomycin A2
CAS:	174390-02-4
Molecular Formula:	C₁₃H₁₉N₃O₆S₂
Molecular Weight:	377.44088
Molecular Structure:
Properties
Safety Data

Other Product

N-[1(S)-(Hydroxymethyl)-2-[(RS)-[[(SS)-methylsulfinyl]methyl]sulfinyl]ethyl]-3-(6-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-2(E)-propenamide
2-Propenamide,N-[1-(hydroxymethyl)-2-[[(methylsulfinyl)methyl]sulfinyl]ethyl]-3-(1,2,3,4-tetrahydro-6-methyl-2,4-dioxo-5-pyrimidinyl)-
(2E)-N-(2-hydroxy-1-{[(4-hydroxyphenyl)sulfinyl]methyl}ethyl)-3-(6-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)prop-2-enamide
2-Propenamide, N-(1-(hydroxymethyl)-2-(((pentylthio)methyl)sulfinyl)ethyl)-3-(1,2,3,4-tetrahydro-2,4-dioxo-5-pyrimidinyl)-, (R-(R*,S*-(E)))-
2(RS)-4-Methyl-1-(3-Methylpyridin-2-yl)-2-phenylpiperazine
methyl 2-amino-5-phenyl-(RS)-(E)-4-pentenoate
2-Propenamide,N-[1-(hydroxymethyl)-2- [(phenylmethyl)sulfinyl]ethyl]-3-(1,2,3,4-tetrahydro- 6-methyl-2,4-dioxo-5-pyrimidinyl)-
(2E)-N-[2-(decylsulfanyl)-1-(hydroxymethyl)ethyl]-3-(6-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)prop-2-enamide
(2E)-N-[2-(benzylsulfinyl)-1-(hydroxymethyl)ethyl]-3-(6-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)prop-2-enamide
1,3-Benzodioxole-5-ethanol,R-[6-[2-(dimethylamino) ethyl]-1,3-benzodioxol-5-yl]-4- (hydroxymethyl)-,(RS)-
(RS)-N-((S)-1-(4-bromophenyl)ethyl)-2-methylpropane-2-sulfinamide
Morphinan-6-one,4,5-epoxy-14-hydroxy-3- methoxy-17-methyl-,hydrochloride,(5R)-,mixt. with (RS)-R-[(1R)-1-(methylamino)ethyl]- benzenemethanol hydrochloride and (1R,2â,4â,5R,7â)-9-methyl-3-oxa-9- azatricyclo[3.3.1.02,4]non-7-yl (RS)-R-(hydroxymethyl)benzeneacetate hydrobromide
1(3H)-Isobenzofuranone,6,7-dimethoxy-3- [(5R)-5,6,7,8-tetrahydro-4-methoxy-6- methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl]-,hydrochloride,(3S)-,mixt. with rel-(RS)-R-[(1R)-1-(dimethylamino)ethyl]- benzenemethanol hydrochloride and 2-(diphenylmethoxy)-N,N-dimethylethanamine hydrochloride
L-Phenylalanine,N2-[[[(1S)-1-carboxy-2-(1Hindol- 3-yl)ethyl]amino]carbonyl]-D-lysyl-Lalloisoleucyl-( RS)-R-amino-4-hydroxybenzenebutanoyl- N-methyl-L-alanyl-,cyclic (5f1)-peptide
L-Phenylalanine,N2-[[[(1S)-1-carboxy-2-(1Hindol- 3-yl)ethyl]amino]carbonyl]-D-lysyl-Lvalyl-( RS)-R-amino-4-hydroxybenzenebutanoyl- N-methyl-L-alanyl-,cyclic (5f1)-peptide
(RS)-2-methyl-N-((S)-5-methyl-1,2,3,4-tetrahydronaphthalen-1-yl)propane-2-sulfinamide
2-Propenamide,N-[(1S)-1-(hydroxymethyl)-2-[(R)-[(octylthio)methyl]sulfinyl]ethyl]-3-(1,2,3,4-tetrahydro-6-methyl-2,4-dioxo-5-pyrimidinyl)-,(2E)-
2-Propenamide,N-[(1S)-1-(hydroxymethyl)-2-[(R)-[(methylthio)methyl]sulfinyl]ethyl]-3-(1,2,3,4-tetrahydro-6-methyl-2,4-dioxo-5-pyrimidinyl)-,(2E)-
2-Propenamide,N-[2-(butylthio)-1-(hydroxymethyl)ethyl]-3-(1,2,3,4-tetrahydro-6-methyl-2,4-dioxo-5-pyrimidinyl)-, (E)-
2-Propenamide,N-[1-methyl-2-[[(methylthio)methyl]sulfinyl]ethyl]-3-(1,2,3,4-tetrahydro-6-methyl-2,4-dioxo-5-pyrimidinyl)-,[R-[R*,S*-(E)]]- (9CI)